By Professor Michael Leonard Friedlander

Journal articles

Audeh MW; Penson RT; Friedlander M; Powell B; Bell-McGuinn KM; Scott C; Weitzel JN; Carmichael J; Tutt A, 2009, 'Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer', Journal of Clinical Oncology, 27, pp. 5500 - 5500, http://dx.doi.org/10.1200/jco.2009.27.15_suppl.5500

Tutt A; Robson M; Garber JE; Domchek S; Audeh MW; Weitzel JN; Friedlander M; Carmichael J, 2009, 'Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer', Journal of Clinical Oncology, 27, pp. CRA501 - CRA501, http://dx.doi.org/10.1200/jco.2009.27.15_suppl.cra501

Bookman MA; Brady MF; McGuire WP; Harper PG; Alberts DS; Friedlander M; Colombo N; Fowler JM; Argenta PA; De Geest K; Mutch DG; Burger RA; Swart AM; Trimble EL; Accario-Winslow C; Roth LM, 2009, 'Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: A phase III trial of the gynecologic cancer intergroup', Journal of Clinical Oncology, 27, pp. 1419 - 1425, http://dx.doi.org/10.1200/JCO.2008.19.1684

Field KM; Jenkins MA; Friedlander ML; McKinley JM; Price MA; Weideman P; Keogh LA; McLachlan SA; Lindeman GJ; Hopper JL; Butow PN; Phillips KA, 2009, 'Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer', European Journal of Cancer, 45, pp. 551 - 560, http://dx.doi.org/10.1016/j.ejca.2008.09.023

Pearce CL; Near AM; Van Den Berg DJ; Ramus SJ; Gentry-Maharaj A; Menon U; Gayther SA; Anderson AR; Edlund CK; Wu AH; Chen X; Beesley J; Webb PM; Holt SK; Chen C; Doherty JA; Rossing MA; Whittemore AS; McGuire V; DiCioccio RA; Goodman MT; Lurie G; Carney ME; Wilkens LR; Ness RB; Moysich KB; Edwards R; Jennison E; Kjaer SK; Hogdall E; Hogdall CK; Goode EL; Sellers TA; Vierkant RA; Cunningham JC; Schildkraut JM; Berchuck A; Moorman PG; Iversen ES; Cramer DW; Terry KL; Vitonis AF; Titus-Ernstoff L; Song H; Pharoah PDP; Spurdle AB; Anton-Culver H; Ziogas A; Brewster W; Galitovskiy V; Chenevix-Trench G; Gertig D; Vanden Bergh T; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D; Robertson G; DeFazio A; Hung J; Chiew YE; Stenlake A; Sullivan H; Brand A; Jaworski R; Harnett P; Wain G; Green A; Moore S; Harrap K; Sadkowsky T; Purdie D; Whiteman D; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Martin K; Ranieri B; White J; Mamers P; Healy D; Jobling T; Maniolitas T; McNealage J; Rogers P; Susil B; Veitch A; Constable J; Ping Tong S; Robinson I; Simpson I; Schmidt T; Shirley H; Viduka S; Tran H; Bilic S, 2009, 'Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium', British Journal of Cancer, 100, pp. 412 - 420, http://dx.doi.org/10.1038/sj.bjc.6604820

Rabaglio M; Sun Z; Price KN; Castiglione-Gertsch M; Hawle H; Thürlimann B; Mouridsen H; Campone M; Forbes JF; Paridaens RJ; Colleoni M; Pienkowski T; Nogaret JM; Láng I; Smith I; Gelber RD; Goldhirsch A; Coates AS, 2009, 'Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial', Annals of Oncology, 20, pp. 1489 - 1498, http://dx.doi.org/10.1093/annonc/mdp033

Friedlander M; Butow P; Stockler M; Gainford C; Martyn J; Oza A; Donovan HS; Miller B; King M, 2009, 'Symptom control in patients with recurrent ovarian cancer: measuring the benefit of palliative chemotherapy in women with platinum refractory/resistant ovarian cancer.', International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 19 Suppl 2, http://dx.doi.org/10.1111/igc.0b013e3181bf7fb8

Colleoni M; Sun Z; Martinelli G; Basser RL; Coates AS; Gelber RD; Green MD; Peccatori F; Cinieri S; Aebi S; Viale G; Price KN; Goldhirsch A, 2009, 'The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: Results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up', Annals of Oncology, 20, pp. 1344 - 1351, http://dx.doi.org/10.1093/annonc/mdp024

Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC, 2009, 'Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity', Journal of clinical oncology - official journal of the American Society of Clinical Oncology, 27, pp. 1243 - 1249

Hickey MS; Peate ML; Saunders C; Friedlander ML, 2009, 'Breast cancer in young women and its impact on reproductive function', Human Reproduction Update, 15, pp. 323 - 339, http://dx.doi.org/10.1093/humupd/dmn064

Chang E; Milne RL; Phillips KA; Figueiredo J; Sangaramoorthy M; Keegan T; Andrulis I; Hopper JL; Goodwin P; O Malley F; Weerasooriya N; Apicella C; Southey MC; Friedlander ML; Giles GG; Whittemore A; West DJ; John E, 2009, 'Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry', Breast Cancer Research and Treatment, 117, pp. 167 - 176

Trimble E; Abrams J; Meyer R; Calvo F; Cazap E; Deye J; Eisenhauer E; Fitzgerald T; Lacombe D; Parmar M; Seibel N; Shankar L; Swart A; Therasse P; Vikram B; von Frenckell R; Friedlander ML; Fujiwara K; Kaplan R; Meunier F, 2009, 'Improving Cancer Outcomes Through International Collaboration in Academic Cancer Treatment Trials', Journal of Clinical Oncology, 27, pp. 5109 - U194

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced Lhermitte’s phenomenon as a manifestation of severe generalized nerve dysfunction', Oncology, 77, pp. 342 - 348

Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced neurotoxicity: Changes in axonal excitability precede development of neuropathy', Brain, 132, pp. 2712 - 2723

Phillips KA; Milne RL; West DJ; Goodwin P; Giles GG; Chang E; Figueiredo J; Friedlander ML; Keegan T; Glendon G; Apicella C; O Malley F; Southey MC; Andrulis I; John E; Hopper JL, 2009, 'Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry', Cancer epidemiology biomarkers and prevention, 18, pp. 1792 - 1797

Peate ML; Meiser B; Hickey MS; Friedlander ML, 2009, 'The fertility-related concerns, needs and preferences of younger women with breast cancer: A systematic review', Breast Cancer Research and Treatment, 116, pp. 215 - 223, http://dx.doi.org/10.1007/s10549-009-0401-6

Viale G; Giobbie-Hurder A; Regan MM; Coates AS; Mastropasqua MG; Dell'Orto P; Maiorano E; MacGrogan G; Braye SG; Oehlschlegel C; Neven P; Orosz Z; Olszewski WP; Knox F; Thuerlimann B; Price KN; Castiglione-Gertsch M; Gelber RD; Gusterson BA; Goldhirsch A, 2008, 'Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole', JOURNAL OF CLINICAL ONCOLOGY, 26, pp. 5569 - 5575, http://dx.doi.org/10.1200/JCO.2008.17.0829

Nagle CM; Olsen CM; Webb PM; Jordan SJ; Whiteman DC; Green AC, 2008, 'Endometrioid and clear cell ovarian cancers - A comparative analysis of risk factors', EUROPEAN JOURNAL OF CANCER, 44, pp. 2477 - 2484, http://dx.doi.org/10.1016/j.ejca.2008.07.009

Olsen CM; Nagle CM; Whiteman DC; Purdie DM; Green AC; Webb PM; Bowtell D; Chenevix-Trench G; Green A; DeFazio A; Gertig D; Traficante N; Moore S; Hung J; Fereday S; Harrap K; Sadkowsky T; Mellon A; Robertson R; Vanden Bergh T; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; CorrGreenish T; Green L; Jackman L; Martin K; Ranieri B; White J; Jayde V; Bowes L; Mamers P; Schmidt T; Shirley H; Viduka S; Tran H; Bilic S; Glavinas L; Proietto A; Braye S; Otton G; Bonaventura T; Stewart J; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Young B; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D; Robertson G; Beale P; Beith J; Carter J; Dalrymple C; Hamilton A; Houghton R; Russell P; Brand A; Jaworski R; Harnett P; Wain G; Crandon A; Cummings M; Horwood K; Obermair A; Wyld D; Nicklin J; Perrin L; Ward B; Davy M; Hall C; Dodd T; Healy T; Pittman K; Henderson D; Hyde S; Miller J; Pierdes J; Blomfield P; Challis D; McIntosh R; Parker A; Brown B; Rome R; Allen D; Grant P; Laurie R; Robbie M; Healy D, 2008, 'Body size and risk of epithelial ovarian and related cancers: A population-based case-control study', International Journal of Cancer, 123, pp. 450 - 456, http://dx.doi.org/10.1002/ijc.23509

Ramus SJ; Vierkant RA; Johnatty SE; Pike MC; Van Den Berg DJ; Wu AH; Pearce CL; Menon U; Gentry-Maharaj A; Gayther SA; DiCioccio RA; McGuire V; Whittemore AS; Song H; Easton DF; Pharoah PDP; Garcia-Closas M; Chanock S; Lissowska J; Brinton L; Terry KL; Cramer DW; Tworoger SS; Hankinson SE; Berchuck A; Moorman PG; Schildkraut JM; Cunningham JM; Liebow M; Kjaer SK; Hogdall E; Hogdall C; Blaakaer J; Ness RB; Moysich KB; Edwards RP; Carney ME; Lurie G; Goodman MT; Wang-Gohrke S; Kropp S; Chang-Claude J; Webb PM; Chen X; Beesley J; Chenevix-Trench G; Goode EL; Bowtell D; Green A; DeFazio A; Gertig D; Traficante N; Moore S; Hung J; Fereday S; Harrap K; Sadkowsky T; Mellon A; Robertson R; Vanden Bergh T; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Martin K; Ranieri B; White J; Jayde V; Bowes VL; Mamers P; Schmidt T; Shirley H; Viduka S; Tran H; Bilic S; Glavinas L; Proietto A; Braye S; Otton G; Bonaventura T; Stewart J; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Young B; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D, 2008, 'Consortium analysis of 7 candidate SNPs for ovarian cancer', International Journal of Cancer, 123, pp. 380 - 388, http://dx.doi.org/10.1002/ijc.23448

Goldstein D; Bennett B; Cameron B; Boyle F; DeSouza P; Wilcken N; Friedlander M; Scott E; Hickie I; Lloyd AAM, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer: Association with hematologic, endocrine, and immune parameters', JOURNAL OF CLINICAL ONCOLOGY, 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.9596

Ravaioli A; Monti F; Regan MM; Maffini F; Mastropasqua MG; Spataro V; Castiglione-Gertsch M; Panzini I; Gianni L; Goldhirsch A; Coates A; Price KN; Gusterson BA; Viale G, 2008, 'p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer', ANNALS OF ONCOLOGY, 19, pp. 660 - 668, http://dx.doi.org/10.1093/annonc/mdm547

Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; Bowtell D; Chenevix-Trench G; Green A; Webb P; DeFazio A; Gertig D; Traficante N; Moore S; Hung J; Fereday S; Harrap K; Sadkowsky T; Mellon A; Robertson R; Vanden Bergh T; Jones M; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Martin K; Ranieri B; White J; Jayde V; Bowes L; Mamers P; Schmidt T; Shirley H; Viduka S; Tran H; Bilic S; Glavinas L; Stuart-Harris R; Kirsten F; Rutovitz J; Clingan P; Glasgow A; Proietto A; Braye S; Otton G; Shannon J; Bonaventura T; Stewart J; Begbie S; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Pavlakis N; Young B; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D; Robertson G; Beale P; Beith J; Carter J; Dalrymple C; Hamilton A; Houghton R; Russell P; Links M; Grygiel J; Hill J; Brand A; Byth K; Jaworski R; Harnett P; Sharma R; Wain G; Purdie D; Whiteman D; Ward B; Papadimos D; Crandon A; Cummings M; Horwood K; Obermair A; Perrin L; Wyld D; Nicklin J; Davy M; Oehler M; Hall C, 2008, 'Skewed X chromosome inactivation and breast and ovarian cancer status: Evidence for X-linked modifiers of BRCA1', Journal of the National Cancer Institute, 100, pp. 1519 - 1529, http://dx.doi.org/10.1093/jnci/djn345

Merritt MA; Green AC; Nagle CM; Webb PM; Bowtell D; Chenevix-Trench G; Green A; DeFazio A; Gertig D; Traficante N; Moore S; Hung J; Fereday S; Harrap K; Sadkowsky T; Mellon A; Robertson R; Vanden Bergh T; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Martin K; Ranieri B; White J; Jayde V; Bowes L; Mamers P; Schmidt T; Shirley H; Viduka S; Tran H; Bilic S; Glavinas L; Proietto A; Braye S; Otton G; Bonaventura T; Stewart J; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Young B; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D; Robertson G; Beale P; Beith J; Carter J; Dalrymple C; Hamilton A; Houghton R; Russell P; Brand A; Jaworski R; Harnett P; Wain G; Crandon A; Cummings M; Horwood K; Obermair A; Wyld D; Nicklin J; Perrin L; Ward B; Davy M; Hall C; Dodd T; Healy T; Pittman K; Henderson D; Hyde S; Miller J; Pierdes J; Blomfield P; Challis D; McIntosh R; Parker A; Brown B; Rome R; Allen D; Grant P; Laurie R; Robbie M; Healy D; Jobling T; Maniolitas T, 2008, 'Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer', International Journal of Cancer, 122, pp. 170 - 176, http://dx.doi.org/10.1002/ijc.23017

Mok K; Juraskova I; Friedlander M, 2008, 'The impact of aromatase inhibitors on sexual functioning: Current knowledge and future research directions', Breast, 17, pp. 436 - 440, http://dx.doi.org/10.1016/j.breast.2008.04.001

Lin CS-Y; Krishnan A; Goldstein D; Friedlander M; Kiernan M, 2008, '457: Sensory nerve excitability in cancer patients treated with oxaliplatin', Journal of Clinical Neuroscience, 15, pp. 362 - 362, http://dx.doi.org/10.1016/j.jocn.2007.07.067

Linger R; Dudakia D; Huddart R; Tucker K; Friedlander ML; Phillips KA; Hogg D; Jewett M; Lohynska R; Daugaard G; Richard S; Chompret A; Stoppa-Lyonnet D; Bonaiti-Pellie C; Heidenreich A; Albers P; Olah E; Geczi L; Bodrogi I; Daly P; Guilford P; Fossi S; Heimdal K; Tjulandin S; Liubchenko L; Stoll H; Weber W; Einhorn L; McMaster M; Korde L; Greene M; Nathanson K; Cortessis V; Easton D; Bishop D; Stratton M; Rapley EA, 2008, 'Analysis of the DNDI gene in men with sporadic and familial testicular germ cell tumors', Genes Chromosomes and Cancer, 47, pp. 247 - 252, http://dx.doi.org/10.1002/gec.20526

Dawson S; Price MA; Jenkins MA; McKinley J; Butow PN; McLachlan S; Lindeman GJ; Weideman P; Friedlander ML; Hopper JL; Phillips KA, 2008, 'Cancer risk management practices of noncarriers within BRCA1/2 mutation - Positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast cancer', Journal of Clinical Oncology, 26, pp. 225 - 232, http://dx.doi.org/10.1200/JCO.2007.11.0262

Meiser B; Tucker K; Friedlander ML; Barlow-Stewart K; Lobb EA; Saunders C; Mitchell GF, 2008, 'Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda', Breast Cancer Research, 10, pp. 216, http://dx.doi.org/10.1186/bcr2194

Park SB; Krishnan AV; Lin CS; Goldstein D; Friedlander ML; Kiernan MC, 2008, 'Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, 15, pp. 3081 - 3094

Jarvis SK; Mok K; Friedlander M; Vancaillie TG, 2008, 'OVERcome Study (Olive Oil Vaginal Exercise and Replens®)', Journal of Minimally Invasive Gynecology, 15, pp. 88S - 88S, http://dx.doi.org/10.1016/j.jmig.2008.09.336

Park SB; Lin CS-Y; Krishnan AV; Friedlander M; Goldstein D; Kiernan MC, 2008, 'Oxaliplatin-induced chronic changes in sensory nerve excitability', Clinical Neurophysiology, 119, pp. e22 - e22, http://dx.doi.org/10.1016/j.clinph.2007.10.044

Yang JL; Qu X; Yu Y; Kohn E; Friedlander ML, 2008, 'Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency', International Journal of Cancer, 123, pp. 258 - 263, http://dx.doi.org/10.1002/ijc.23535

Beesley J; Jordan SJ; Spurdle AB; Song H; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; McGuire V; Whittemore AS; Gayther SA; Pharoah PDP; Webb PM; Chenevix-Trench G; Bowtell D; Green A; DeFazio A; Gertig D; Traficante N; Moore S; Hung J; Fereday S; Harrap K; Sadkowsky T; Mellon A; Robertson R; Vanden Bergh T; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Martin K; Ranieri B; White J; Jayde V; Bowes L; Mamers P; Schmidt T; Shirley H; Viduka S; Tran H; Bilic S; Glavinas L; Proietto A; Braye S; Otton G; Bonaventura T; Stewart J; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Young B; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D; Robertson G; Beale P; Beith J; Carter J; Dalrymple C; Hamilton A; Houghton R; Russell P; Brand A; Jaworski R; Harnett P; Wain G; Crandon A; Cummings M; Horwood K; Obermair A; Wyld D; Nicklin J; Perrin L; Ward B; Davy M; Hall C; Dodd T; Healy T; Pittman K; Henderson D; Hyde S; Miller J; Pierdes J; Blomfield P; Challis D; McIntosh R; Parker A, 2007, 'Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: Results from two Australian studies and an additional validation set', Cancer Epidemiology Biomarkers and Prevention, 16, pp. 2557 - 2565, http://dx.doi.org/10.1158/1055-9965.EPI-07-0542

Olsen CM; Bain CJ; Jordan SJ; Nagle CM; Green AC; Whiteman DC; Webb PM; Bowtell D; Chenevix-Trench G; Green A; Defazio A; Gertig D; Traficante N; Moore S; Hung J; Fereday S; Harrap K; Sadkowsky T; Mellon A; Robertson R; Vanden Bergh T; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Martin K; Ranieri B; White J; Jayde V; Bowes L; Mamers P; Schmidt T; Shirley H; Viduka S; Tran H; Bilic S; Glavinas L; Proietto A; Braye S; Otton G; Bonaventura T; Stewart J; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Young B; Camaris C; Crouch R; Edwards L; Hacker N; Marsden D; Robertson G; Beale P; Beith J; Carter J; Dalrymple C; Hamilton A; Houghton R; Russell P; Brand A; Jaworski R; Harnett P; Wain G; Crandon A; Cummings M; Horwood K; Obermair A; Wyld D; Nicklin J; Perrin L; Ward B; Davy M; Hall C; Dodd T; Healy T; Pittman K; Henderson D; Hyde S; Miller J; Pierdes J; Blomfield P; Challis D; McIntosh R; Parker A; Rome R; Allen D; Grant P; Laurie R; Robbie M; Healy D, 2007, 'Recreational physical activity and epithelial ovarian cancer: A case-control study, systematic review, and meta-analysis', Cancer Epidemiology Biomarkers and Prevention, 16, pp. 2321 - 2330, http://dx.doi.org/10.1158/1055-9965.EPI-07-0566

McKinley JM; Weideman PC; Jenkins MA; Friedlander ML; Hopper JL; McLachlan SA; Lindeman GJ; Phillips KA, 2007, 'Prostate screening uptake in Australian BRCA1 and BRCA2 carriers', Hereditary Cancer in Clinical Practice, 5, pp. 161 - 163

Colleoni M; Gelber S; Simoncini E; Pagani O; Gelber RD; Price KN; Castiglione-Gertsch M; Coates AS; Goldhirsch A; Thürlimann B; Castiglione M; Collins JP; Cortés Funes H; Green M; Hiltbrunner A; Holmberg SB; Hossfeld DK; Láng I; Lindtner J; Paganetti F; Rudenstam CM; Stahel R; Senn HJ; Veronesi A; Egli G; Rabaglio M; Studer R; Ruepp B; Maibach R; Marbot E; Strausak M; Gelber R; Cole B; Regan M; Zahrieh D; Sun Z; Bernhard J; Hürny C; Gusterson B; Viale G; Blacher L; Celano J; Isley M; Hinkle R; Lippert S; Scott K; Crivellari D; Monfardini S; Galligioni E; Magri MD; Buonadonna A; Massarut S; Rossi C; Candiani E; Carbone A; Volpe R; Roncadin M; Arcicasa M; Coran F; Morassut S; Marini G; Marpicati P; Braga M; Grigolato P; Lucini L; Martinelli G; Orlando L; Nolè F; Torrisi R; De Pas T; de Braud F; Cinieri S; Peccatori F; Luini A; Orecchia R; Renne G; Costa A; Zurrida S; Veronesi P; Sacchini V; Galimberti V; Intra M; Veronesi U; Ravaioli A; Tassinari D; Oliverio G; Barbanti F; Rinaldi P; Pini E; Drudi G; Antimi M; Minelli M; Bellini V; Porzio R; Pernazza E; Santeusanio G; Spagnoli LG; Foladore S; Foghin L, 2007, 'Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: Results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93', Annals of Oncology, 18, pp. 1177 - 1184, http://dx.doi.org/10.1093/annonc/mdm091

Easton DF; Pooley KA; Dunning AM; Pharoah PDP; Thompson D; Ballinger DG; Struewing JP; Morrison J; Field H; Luben R; Wareham N; Ahmed S; Healey CS; Bowman R; Meyer KB; Haiman CA; Kolonel LK; Henderson BE; Le Marchand L; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Eccles D; Evans DG; Peto J; Fletcher O; Johnson N; Seal S; Stratton MR; Rahman N; Chenevix-Trench G; Bojesen SE; Nordestgaard BG; Axelsson CK; Garcia-Closas M; Brinton L; Chanock S; Lissowska J; Peplonska B; Nevanlinna H; Fagerholm R; Eerola H; Kang D; Yoo KY; Noh DY; Ahn SH; Hunter DJ; Hankinson SE; Cox DG; Hall P; Wedren S; Liu J; Low YL; Bogdanova N; Schürmann P; Dörk T; Tollenaar RAEM; Jacobi CE; Devilee P; Klijn JGM; Sigurdson AJ; Doody MM; Alexander BH; Zhang J; Cox A; Brock IW; MacPherson G; Reed MWR; Couch FJ; Goode EL; Olson JE; Meijers-Heijboer H; Van Den Ouweland A; Uitterlinden A; Rivadeneira F; Milne RL; Ribas G; Gonzalez-Neira A; Benitez J; Hopper JL; McCredie M; Southey M; Giles G; Schroen C; Justenhoven C; Brauch H; Hamann U; Ko YD; Spurdle AB; Beesley J; Chen X; Mannermaa A; Kosma VM; Kataja V; Hartikainen J; Day NE, 2007, 'Genome-wide association study identifies novel breast cancer susceptibility loci', Nature, 447, pp. 1087 - 1093, http://dx.doi.org/10.1038/nature05887

Friedlander M; Hancock KC; Benigno B; Rischin D; Messing M; Stringer CA; Tay EH; Kathman S; Matthys G; Lager JJ, 2007, 'Pazopanib (GW786034) is active in women with advanced epithelial ovarian, fallopian tube and peritoneal cancers: Initial results of a phase II study', Journal of Clinical Oncology, 25, pp. 5561 - 5561, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.5561

Hogg R; Scurry JP; Kim SN; Friedlander ML; Hacker NF, 2007, 'Microinvasion links ovarian serous borderline tumour and grade 1 invasive carcinoma', Gynecologic Oncology, 106, pp. 44 - 51

Clarke S; Goldstein D; Mitchell P; Michael M; Beale P; Friedlander ML, 2007, 'Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy', Clinical Colorectal Cancer, 6, pp. 578 - 582

Friedlander ML; Buck MD; Wyld D; Findlay M; Fitzharris B; De Souza PL; Davies TM; Kalimi G; Allan S; Perez DM; Harnett PH, 2007, 'Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer', International Journal of Gynecological Cancer, 17, pp. 350 - 358

Bennett BK; Goldstein D; Lloyd AROLA; Friedlander ML; Hickie IB, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135

Bennett BK; Goldstein D; Friedlander ML; Hickie IB; Lloyd AR, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: A qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135

Phillips KA; Jenkins MA; Lindeman GJ; Mclachlan SA; Mckinley JM; Weideman PC; Hopper JL; Friedlander ML, 2006, 'Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: A prospective cohort study', Clinical Genetics, 70, pp. 198 - 206, http://dx.doi.org/10.1111/j.1399-0004.2006.00665.x

Dawson S; McKinley J; Jenkins M; McLachlan S; Lindeman G; Friedlander M; Hopper J; Phillips K, 2006, 'Cancer risk management practices of non-carriers within BRCA1/2 mutation positive families in the Kathleen Cunningham Consortium for Research into Familial Breast Cancer (kConFab)', Journal of Clinical Oncology, 24, pp. 1020 - 1020, http://dx.doi.org/10.1200/jco.2006.24.18_suppl.1020

Lutty GA; Chan-Ling T; Phelps DL; Adamis AP; Berns KI; Chan CK; Cole CH; D'Amore PA; Das A; Deng WT; Dobson V; Flynn JT; Friedlander M; Fulton A; Good WV; Grant MB; Hansen R; Hauswirth WW; Hardy RJ; Hinton DR; Hughes S; McLeod DS; Palmer EA; Patz A; Penn JS; Raisler BJ; Repka MX; Saint-Geniez M; Shaw LC; Shima DT; Smith BT; Smith LEH; Tahija SG; Tasman W; Trese MT, 2006, 'Proceedings of the Third International Symposium on Retinopathy of Prematurity: An update on ROP from the lab to the nursery (November 2003, Anaheim, California)', Molecular Vision, 12, pp. 532 - 580

Harrison ML; Hoskins P; Du Bois A; Quinn M; Rustin GJS; Ledermann JA; Baron-Hay S; Friedlander ML, 2006, 'Small cell of the ovary, hypercalcemic type - Analysis of combined experience and recommendation for management. A GCIG study', Gynecologic Oncology, 100, pp. 233 - 238, http://dx.doi.org/10.1016/j.ygyno.2005.10.024

Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR; Adams J; Baum M; Buzdar A; Cella D; Coleman R; Constenla M; Cuzick J; Distler W; Dowset M; Eastell R; Fallowfield LJ; Forbes J; George WD; Gray J; Guastalla JP; Hellmund R; Hoctin-Boes G; Houghton J; Williams N; Howell A; Klijn JGM; Locker GY; Mackey J; Mansel RE; Nabholtz JM; Naglkalnai T; Nicolucci A; Nylen U; Sainsbury R; Sapunar F; Suarez-Mendez VJ; Tobias JS; Friedlander M; Richardson G; Makar A; Neven P; Mention J; Distler DW; Eiermann W; Mouritis M; Wamsteker ; Campos O; Candeias OR; Landers G; Llombart A; Menjon S; Repolle´s M; Lindahl B; Ingvar C; Bharbra K; Bjornsson S; Charnock F; Cutner A; De Bono M; Evans-Jones J; Glass M; Holt S; Jones A; Kremer ; O'Donovan P; Omara-Boto TA; Onwude J; Phillips K; Price J; Samtaney N; Seif M; Doe A; Foster E; Woolas R; Buyse M; Wale C; Margolese R; Body JJ, 2006, 'The ATAC ('Arimidex', tamoxifen, alone or in combination) adjuvant breast cancer trial: First results of the endometrial sub-protocol following 2 years of treatment', Human Reproduction, 21, pp. 545 - 553, http://dx.doi.org/10.1093/humrep/dei322

Tiller K; Meiser B; Gaff C; Kirk J; Dudding T; Phillips KA; Friedlander ML; Tucker K, 2006, 'A randomised controlled trial of a decision aid for women at increased risk of ovarian cancer', Medical Decision Making, 26, pp. 360 - 372

Back to profile page